The phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) axis orchestrates key processes in cellular metabolism, growth, and survival, and constitutes a central oncogenic driver across multiple tumor types. The gene discussed is MTOR; the disease is neoplasm.